Resistance to Second-Line Antituberculosis Drugs and Delay in Drug Susceptibility Testing among Multidrug-Resistant Tuberculosis Patients in Shanghai

Introduction. Second-line antituberculosis drugs (SLDs) are used for treating multidrug-resistant tuberculosis (MDR-TB). Prolonged delays before confirming MDR-TB with drug susceptibility testing (DST) could result in transmission of drug-resistant strains and inappropriate use of SLDs, thereby incr...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yong, Yuan, Zhengan, Shen, Xin, Wu, Jie, Wu, Zheyuan, Xu, Biao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5019859/
https://www.ncbi.nlm.nih.gov/pubmed/27652260
http://dx.doi.org/10.1155/2016/2628913

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5019859/
https://www.ncbi.nlm.nih.gov/pubmed/27652260
http://dx.doi.org/10.1155/2016/2628913

Ejemplares similares